Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Seeing beyond sight: rehab program targets mental health in AMD

NCT ID NCT06906003

First seen Jun 11, 2026 · Last updated Jun 20, 2026 · Updated 3 times

Summary

This study looks at whether a 60-day visual rehabilitation program can reduce anxiety and depression in people with advanced age-related macular degeneration (AMD). Twenty-two participants with moderate to severe vision loss will attend five group sessions focused on practical skills like coin recognition, reading stories, using smartphone apps, and voice assistants. Their anxiety and depression levels will be measured before and after the program using standard questionnaires.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS Fondazione G.B.Bietti

    RECRUITING

    Rome, Italy, 00184, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

visual rehabilitation program

What this could lead to

If it works, this could show that simple visual rehab activities like coin recognition and using voice assistants help ease anxiety and depression in people with advanced AMD.

What could go wrong

This is a very small observational study with only 22 participants and no comparison group, so results may not be widely applicable. The program is short (60 days) and may not lead to lasting changes.

Conditions

The condition(s) this trial relates to.

age-related macular degeneration anxiety anxiety disorder depressive disorder dry age related macular degeneration macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.